Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Multicenter open-label randomized controlled clinical trialMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03728049
- Collaborators
- Siemens Healthineers, France
- Ministry of Health, France
- Investigators
- Principal Investigator: Eric Vanbelle, MD University Hospital, Lille